100 related articles for article (PubMed ID: 30223097)
1. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
2. Two affinities for a single antagonist at the neuronal NK1 tachykinin receptor: evidence from quantitation of receptor endocytosis.
Jenkinson KM; Southwell BR; Furness JB
Br J Pharmacol; 1999 Jan; 126(1):131-6. PubMed ID: 10051129
[TBL] [Abstract][Full Text] [Related]
3. Prenatal nicotinic exposure upregulates pulmonary C-fiber NK1R expression to prolong pulmonary C-fiber-mediated apneic response.
Zhao L; Zhuang J; Zang N; Lin Y; Lee LY; Xu F
Toxicol Appl Pharmacol; 2016 Jan; 290():107-15. PubMed ID: 26524655
[TBL] [Abstract][Full Text] [Related]
4. Relationships between neurokinin receptor-expressing interstitial cells of Cajal and tachykininergic nerves in the gut.
Faussone-Pellegrini MS
J Cell Mol Med; 2006; 10(1):20-32. PubMed ID: 16563219
[TBL] [Abstract][Full Text] [Related]
5. Rapid elucidation of agonist-driven regulation of the neurokinin 1 receptor using a GPCR phosphorylation immunoassay.
Blum NK; Schaffner A; Drube J; Nagel F; Reinscheid RK; Hoffmann C; Schulz S
Eur J Pharmacol; 2024 Jun; 973():176587. PubMed ID: 38642667
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity.
Recio R; Lerena P; Pozo E; Calderón-Montaño JM; Burgos-Morón E; López-Lázaro M; Valdivia V; Pernia Leal M; Mouillac B; Organero JÁ; Khiar N; Fernández I
J Med Chem; 2021 Jul; 64(14):10350-10370. PubMed ID: 34236855
[TBL] [Abstract][Full Text] [Related]
7. Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor.
Schwartz L; Spitsin SV; Meshki J; Tuluc F; Douglas SD; Wolfe JH
J Neurovirol; 2013 Jun; 19(3):219-27. PubMed ID: 23765222
[TBL] [Abstract][Full Text] [Related]
8. A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain.
Ramírez-García PD; Retamal JS; Shenoy P; Imlach W; Sykes M; Truong N; Constandil L; Pelissier T; Nowell CJ; Khor SY; Layani LM; Lumb C; Poole DP; Lieu T; Stewart GD; Mai QN; Jensen DD; Latorre R; Scheff NN; Schmidt BL; Quinn JF; Whittaker MR; Veldhuis NA; Davis TP; Bunnett NW
Nat Nanotechnol; 2019 Dec; 14(12):1150-1159. PubMed ID: 31686009
[TBL] [Abstract][Full Text] [Related]
9. Suppressing the Substance P-NK1R Signalling Protects Mice against Sepsis-Associated Acute Inflammatory Injury and Ferroptosis in the Liver and Lungs.
Zhu Z; Chambers S; Bhatia M
Antioxidants (Basel); 2024 Feb; 13(3):. PubMed ID: 38539834
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Evaluation of a Neurokinin-1 Receptor-Targeted Near-IR Dye for Fluorescence-Guided Surgery of Neuroendocrine Cancers.
Kanduluru AK; Srinivasarao M; Low PS
Bioconjug Chem; 2016 Sep; 27(9):2157-65. PubMed ID: 27529726
[TBL] [Abstract][Full Text] [Related]
11. Moving out of CF
Witoszka K; Matalińska J; Misicka A; Lipiński PFJ
ChemMedChem; 2023 Dec; 18(23):e202300315. PubMed ID: 37821725
[TBL] [Abstract][Full Text] [Related]
12. Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic Approach.
Muñoz M; Coveñas R
Cancers (Basel); 2015 Jul; 7(3):1215-32. PubMed ID: 26154566
[TBL] [Abstract][Full Text] [Related]
13. Functional neuronal circuits promote disease progression in cancer.
Restaino AC; Walz A; Vermeer SJ; Barr J; Kovács A; Fettig RR; Vermeer DW; Reavis H; Williamson CS; Lucido CT; Eichwald T; Omran DK; Jung E; Schwartz LE; Bell M; Muirhead DM; Hooper JE; Spanos WC; Drapkin R; Talbot S; Vermeer PD
Sci Adv; 2023 May; 9(19):eade4443. PubMed ID: 37163587
[TBL] [Abstract][Full Text] [Related]
14. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
Nizam E; Köksoy S; Erin N
Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
[TBL] [Abstract][Full Text] [Related]
15. The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
Muñoz M; Coveñas R
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32962202
[TBL] [Abstract][Full Text] [Related]
16. Advances in the research and application of neurokinin-1 receptor antagonists.
Hong X; Ma J; Zheng S; Zhao G; Fu C
J Zhejiang Univ Sci B; 2024 Feb; 25(2):91-105. PubMed ID: 38303494
[TBL] [Abstract][Full Text] [Related]
17. Neuroimmune communication in allergic rhinitis.
Zhou Y; Chen R; Kong L; Sun Y; Deng J
Front Neurol; 2023; 14():1282130. PubMed ID: 38178883
[TBL] [Abstract][Full Text] [Related]
18. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.
Coveñas R; Rodríguez FD; Robinson P; Muñoz M
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
